This preliminary retrospective study evaluated whether immunochemical staining for IMP3 helps in differentiating endoscopically resectable PT (adenomas and adenocarcinomas without infiltration into the sphincter of Oddi) from papillary adenocarcinomas with an invasion into the sphincter of Oddi, which we considered the primary endpoint. The gene discussed is IMP3; the disease is adenocarcinoma.